Noradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorder

Citations Over TimeTop 10% of 2007 papers

Abstract

The catecholamine norepinephrine is a critical effector of the mammalian stress response and has been implicated in the pathophysiology of posttraumatic stress disorder (PTSD)-a syndrome intrinsically related to the experience of extraordinary stress. Symptom-linked hypernoradrenergic derangements have been observed in PTSD and several studies have examined the potential therapeutic effects of agents that dampen the centrally hyperactive noradrenergic state. These agents include compounds that decrease norepinephrine release (e.g. centrally acting alpha(2) agonists such as clonidine) and those which block post-synaptic norepinephrine receptors (e.g. centrally acting alpha(1) or beta receptor antagonists such as prazosin or propranolol). In this article, we review studies of central noreadrenergic hyperactivity under both basal and challenge conditions and explore the evidence for these derangements as potential psychopharmacologic targets in patients with PTSD. Given the significant involvement of CNS norepinephrine hyperactivity in PTSD, and its link to intrusive and hyperarousal symptoms, it is not surprising that interventions directed at this system have therapeutic potential in PTSD. The utility of these anti-adrenergics in the clinical treatment of PTSD remains to be determined, though it is possible that they may prove to have primary roles in a disorder that is only modestly responsive to antidepressant treatment.

Related Papers

• → INTERACTIONS BETWEEN PRAZOSIN, CLONIDINE AND DIRECT VASODILATORS IN THE ANAESTHETIZED RAT(1978)11 cited
• → Chronic Treatment with Prazosin Causes a Subtype-specific Increase in the α1-Adrenoceptor Density of the Stressed Rat Cerebral Cortex(1997)5 cited
• → Prazosin partly blocks clonidine-induced hypotension in patients with essential hypertension(1987)2 cited
• → The Interaction between Prazosin and Clonidine(1978)6 cited
• → Interaction between clonidine and alpha blockers(1985)2 cited